• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[I-125粒子植入治疗前列腺癌后的组织学随访]

[Histological follow-up after implantation of grains of I-125 for prostatic cancer].

作者信息

Nadalini V F, Giglio C, Bruttini G, Positano N, Fassone M, Fasce L, Medica M, de Angelis P, Fantacci O, Scarpati D, Ledda S

出版信息

J Urol (Paris). 1983;89(3):187-190.

PMID:6875299
Abstract

The authors report a preliminary study of 12 cases of carcinoma of the prostate confined to the prostate (T1, T2, T3, NO, MO) treated by pelvic lymphadenectomy and the implantation of grains of I 125 in the prostatic tissue. Irradiation continued for six months, providing most dose of 100 Gy in the prostate. Interstitial irradiation caused not only the destruction of tumour cells but also "radiation prostate" lesions with vascular obliteration which itself caused sufficient impairment of the vitality of the prostatic tissue for any residual tumour to disappear with a frequency which increased with the time elapsing between the follow up prostatic biopsy and the implantation of radioactive iodine. Experience remains limited but the initial figures given here suggest the validity of continuing along these lines.

摘要

作者报告了一项对12例局限于前列腺的前列腺癌(T1、T2、T3、N0、M0)患者的初步研究,这些患者接受了盆腔淋巴结清扫术,并在前列腺组织中植入了碘125粒子。照射持续6个月,前列腺的最大剂量为100 Gy。间质照射不仅导致肿瘤细胞的破坏,还引发了伴有血管闭塞的“放射性前列腺”病变,这本身就足以损害前列腺组织的活力,使得任何残留肿瘤消失,其消失频率随着前列腺活检与放射性碘植入之间时间的推移而增加。经验仍然有限,但此处给出的初步数据表明沿这些方向继续研究的有效性。

相似文献

1
[Histological follow-up after implantation of grains of I-125 for prostatic cancer].[I-125粒子植入治疗前列腺癌后的组织学随访]
J Urol (Paris). 1983;89(3):187-190.
2
[Results of interstitial radiotherapy using I-125 seeds in the treatment of prostatic cancer].[I-125 粒子组织间放疗治疗前列腺癌的结果]
Strahlenther Onkol. 1988 Apr;164(4):195-201.
3
Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.125I前列腺近距离放射治疗后患者报告的长期泌尿发病率及相关生活质量变化的前瞻性评估
Brachytherapy. 2003;2(1):32-9. doi: 10.1016/S1538-4721(03)00012-6.
4
Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.采用放射治疗肿瘤学组(RTOG)9406方案IV级剂量水平对前列腺癌进行三维放射治疗后的毒性反应
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):735-42. doi: 10.1016/S0360-3016(03)01578-5.
5
Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.现代前列腺近距离放射治疗。219例患者的前列腺特异性抗原结果,随访观察长达12年。
Cancer. 2000 Jul 1;89(1):135-41.
6
[Changes of edema associated with I-125 prostate brachytherapy].[与I-125前列腺近距离放射治疗相关的水肿变化]
Nihon Igaku Hoshasen Gakkai Zasshi. 2005 Oct;65(4):411-8.
7
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.局部前列腺癌患者增加外照射剂量可改善无生化复发生存率:九家机构1994年和1995年治疗患者的综合经验
Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):415-9. doi: 10.1016/j.ijrobp.2004.05.018.
8
PSA kinetics following I-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer.
Radiat Oncol Investig. 1999;7(1):30-5. doi: 10.1002/(SICI)1520-6823(1999)7:1<30::AID-ROI4>3.0.CO;2-8.
9
[Cancer of the prostate: technics of curietherapy. Review of the literature and experience at the Institut Gustave-Roussy].
Bull Cancer. 1985;72(6):578-84.
10
Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.神经周围浸润并不能预测前列腺近距离放射治疗后的生化结果。
Cancer J. 2001 Sep-Oct;7(5):404-12.